Berlin, Germany – 8 April 2024: A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is ...
April 30, 2004 — An infusion of n-3 polyunsaturated fatty acids (PUFA) had immediate inhibitory effects on sustained ventricular tachycardia, according to the results of a pilot study published in the ...
Thus, the interlacing of viable and nonviable myocardium is capable of satisfying the three conditions required for initiation and maintenance of a reentrant rhythm: (1) at least two functionally (or ...
Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...
Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia
Background A 68-year-old man diagnosed with primary plasma-cell leukemia was given thalidomide maintenance treatment for his disease. He had previously failed induction therapy with cyclophosphamide, ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...
Ventricular tachycardia, or V-tach (VT), and supraventricular tachycardia (SVT) are two types of tachycardia. The term “tachycardia” refers to a heart rate of more than 100 beats per minute. The key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback